Nanocarriers Usage for Drug Delivery in Cancer Therapy

Nanocarriers Usage for Drug Delivery in Cancer Therapy Publisher

Khodabandehloo H¹ ; Zahednasab H² ; Hafez AA³

Show Affiliations

1. Department of Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2. Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
3. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: International Journal of Cancer Management Published:2016

Abstract

Conventional therapeutic agents have displayed significant shortcomings. For this reason, important achievements have effectively made in biotechnology for delivering the therapeutic agents to the site of action, and diminish side effects. Polymeric carriers, micelles, dendrimers, liposomes, solid lipid carriers, gold carriers, viral carriers, nanotubes and magnetic carriers incorporating cytotoxic therapeutics have developed. To improve biological distribution of therapeutic drugs, some modified carriers have designed in optimal size and modified surface area. Delivery of carriers to target cells could be done by passive and active targeting. © 2016, Iranian Journal of Cancer Prevention.

Related Docs

View other Related Docs

1. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)

2. Application of Nano-Based Systems for Drug Delivery and Targeting: A Review, Journal of Nanoparticle Research (2020)

3. Biocompatibility and Nanostructured Materials: Applications in Nanomedicine, Artificial Cells# Nanomedicine and Biotechnology (2017)

4. Nanoparticles and Targeted Drug Delivery in Cancer Therapy, Immunology Letters (2017)

5. Does Pharmacodynamics of Drugs Change After Presenting Them As Na-Noparticles Like Their Pharmacokinetics?, Current Drug Targets (2020)

6. Controlled Anti-Cancer Drug Release Through Advanced Nano-Drug Delivery Systems: Static and Dynamic Targeting Strategies, Journal of Controlled Release (2020)

7. Nexus Between in Silico and in Vivo Models to Enhance Clinical Translation of Nanomedicine, Nano Today (2021)

8. Ph-Responsive Polymer in a Core–Shell Magnetic Structure As an Efficient Carrier for Delivery of Doxorubicin to Tumor Cells, International Journal of Polymeric Materials and Polymeric Biomaterials (2018)

Experts (# of related papers)

View all Related Experts

Mahmood Doosti (1)

Hossein Ghanbari (1)

Style	Citing Format
MLA	Khodabandehloo H, Zahednasab H, Hafez AA. "Nanocarriers Usage for Drug Delivery in Cancer Therapy." International Journal of Cancer Management, vol. 9, no. 2, 2016, pp. -.
APA	Khodabandehloo H, Zahednasab H, Hafez AA (2016). Nanocarriers Usage for Drug Delivery in Cancer Therapy. International Journal of Cancer Management, 9(2), -.
Chicago	Khodabandehloo H, Zahednasab H, Hafez AA. "Nanocarriers Usage for Drug Delivery in Cancer Therapy." International Journal of Cancer Management 9, no. 2 (2016): -.
Harvard	Khodabandehloo H, Zahednasab H, Hafez AA (2016) 'Nanocarriers Usage for Drug Delivery in Cancer Therapy', International Journal of Cancer Management, 9(2), pp. -.
Vancouver	Khodabandehloo H, Zahednasab H, Hafez AA. Nanocarriers Usage for Drug Delivery in Cancer Therapy. International Journal of Cancer Management. 2016;9(2):-.
BibTex	@article{ author = {Khodabandehloo H and Zahednasab H and Hafez AA}, title = {Nanocarriers Usage for Drug Delivery in Cancer Therapy}, journal = {International Journal of Cancer Management}, volume = {9}, number = {2}, pages = {-}, year = {2016} }
RIS	TY - JOUR AU - Khodabandehloo H AU - Zahednasab H AU - Hafez AA TI - Nanocarriers Usage for Drug Delivery in Cancer Therapy JO - International Journal of Cancer Management VL - 9 IS - 2 SP - EP - PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract